Scholars Central

Research articlePublished 2011

Perioperative Administration of Fibrinogen is Associated with Increased Risk of Postoperative Thromboembolic Complications after Cardiac Surgery

Authors: Carl-Johan Jakobsen, Mariann Tang, Lars Folkersen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Fibrinogen is a key protein in achieving and maintaining haemostasis. Prophylactic fibrinogen has been shown to reduce bleeding after coronary artery bypass graft (CABG) and studies have reported an inverse correlation between preoperative plasma concentration of fibrinogen and the volume of postoperative bleeding after CABG. This indicates that preoperative fibrinogen plasma concentration, even within the normal range, is a limiting factor for haemostasis after cardiac surgery. In theory, fibrinogen might induce a risk for thrombosis and hypercoagulability. The reported adverse effects of fibrinogen administration are few, without clinical significance or blurred by the use of other medications influencing coagulation; the potential adverse effects of prophylactic fibrinogen on larger groups of cardiac surgery patients seem unidentified. Material and methods: All patients undergoing cardiac surgery at Aarhus University Hospital in 2008 and 2009 were obtained from West Denmark Heart Registry (n=1876) and merged with our patient data management system to identify patients receiving fibrinogen, aprotinin and recombinant VIIa perioperatively. The outcomes considered included in-hospital myocardial infarction, stroke and need for dialysis. Model-based Poisson regression analysis was used to estimate adjusted risk ratios to identify independent factors with impact on outcomes. Results: Independent risk factors (OR (95% CI)) for postoperative stroke were preoperative neurological dysfunction: 3.10 (1.46- 6.57), valve replacement: 2.12 (1.09 - 4.12), aortic surgery: 3.57 (1.35 - 9.46) and perioperative fibrinogen infusion: 2.69 (1.24 - 5.87). Independent risk factors for postoperative dialysis were s-creatinine > 200 µmol/L: 8.21 (4.12 - 16.5), age: 1.16 (1.00 - 1.33), Euroscore defined general-: 1.32 (1.17 - 1.48), and cardiac state: 1.27 (1.12 - 1.44) together with perioperative aprotinin: 3.42 (1.74 - 6.77) and fibrinogen infusion: 3.77 (2.02 - 7.03). Conclusion: This study indicates that perioperative administration of fibrinogen could be associated with increased risk of neurological thromboembolic complication and renal failure and thus have potential thromboembolic side effects. However, further studies are warranted to clarify any causal association between postoperative complications and perioperative infusion of fibrinogen. The results further emphasized that administration of fibrinogen should be in accordance with recommended guidelines and always guided by whole blood coagulation evaluation.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Blood Disorders & Transfusion.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood Disorders & Transfusion
  • SubjectHaematology
  • BylineArticles whose byline prints “Carl-Johan Jakobsen”
  • BylineArticles whose byline prints “Mariann Tang”
  • BylineArticles whose byline prints “Lars Folkersen”